VX1 vs Fetal EchoScan
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
VX1 assists cardiac electrophysiologists during adult ablation procedures for atrial fibrillation and tachycardia, focusing on real-time electrogram identification. Fetal EchoScan, conversely, supports clinicians in prenatal ultrasound screening for congenital heart defects, providing real-time guidance and automated detection. While both leverage AI in cardiology, they address distinct patient populations and clinical workflows, making them suitable for different specialized needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Volta Medical's VX1 is an FDA-cleared AI software designed to assist cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. Brightheart's Fetal EchoScan is an FDA-cleared AI-powered ultrasound screening software that assists clinicians in the prenatal detection of congenital heart defects.
VX1 is primarily designed for cardiac electrophysiologists within Cardiology. Fetal EchoScan supports clinicians across Cardiology, Maternal-Fetal Medicine, and Radiology specialties.
VX1 is deployed as software integrated with existing electrophysiology (EP) lab mapping and recording systems. Fetal EchoScan is a cloud-based software-only device that integrates with existing ultrasound workflows and is DICOM compatible, offering a cart-side tablet display for real-time AI analysis.
VX1 provides AI-guided real-time identification of dispersed electrograms, aiming to reduce inter-operator variability and standardize outcomes during ablation procedures. Fetal EchoScan offers automated detection of congenital heart defects and real-time guidance and feedback during ultrasound scans to ensure exam completeness and standardization of fetal heart assessments.
For VX1, HIPAA compliance and Business Associate Agreement (BAA) status are not explicitly stated in the provided information, and users should contact Volta Medical for details. For Fetal EchoScan, HIPAA compliance and BAA are likely, and users should contact Brightheart for specific vendor information.
More Comparisons
Backers
Who funded each tool's parent company.